Researchers at Washington University in St. Louis have a unique resource in the form of the Center for Biomolecular ...
Greenwich's $3.81 million cash position covers less than two months of operations, making near-term financing highly likely ...
Patients with Waldenström Non-Hodgkin lymphoma in the U.S. achieved durable complete responses of up to 15 months using a chemotherapy-free CD19 CAR-NK (chimeric antigen receptor natural killer) cell ...
Amgen Inc. Buy thesis: strong pipeline, 12% Q3 2025 revenue growth and MariTide obesity upside. Click for this updated look ...
An error has occurred. Please try again. With a Lewiston Sun Journal subscription, you can gift 5 articles each month. It looks like you do not have any active ...
What keeps our cells the right size? Scientists have long puzzled over this fundamental question, since cells that are too large or too small are linked to many diseases. Until now, the genetic basis ...
Cilta-cel showed high 30-month PFS and OS rates in standard-risk relapsed/refractory multiple myeloma, indicating potential for a cure fraction. The trial reported a 100% overall response rate in ...
Doctors have admitted to performing “non-standard” gender-affirming procedures on youngsters and sometimes base treatment purely on cosmetic goals — as they see a spike in patients seeking out ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...
BELLINGHAM, WASH. — The Non-GMO Project has published the first version of its Non-UPF Verified Standard certification, a third-party certification that defines what foods qualify as not ...
Non-UPF Verified debuted its “work in progress” standard for CPG brands this week - months after the initiative launched. The standard was crafted in partnership with 16 pilot brands and in ...
SAN CARLOS, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel ...